SCHEMBL3864427

SCHEMBL3864427

CC(O)[C@@H](O)CN1C(=O)C=CC1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 11/20 0.44
ALDH1A1 P00352 3/20 0.44
BLM P54132 2/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
GMNN O75496 1/20 0.44
THPO P40225 1/20 0.44
PMP22 Q01453 1/20 0.44
FAAH O00519 5/20 0.39
HPGD P15428 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C19 P33261 1/20 0.38
WRN Q14191 1/20 0.38
HIF1A Q16665 1/20 0.38
HSP90AA1 P07900 1/20 0.38
TLR9 Q9NR96 1/20 0.38
TP53 P04637 1/20 0.38
PKM P14618 1/20 0.38
XBP1 P17861 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3864424 1.00 MGLL (0.44) MGLLALDH1A1BLMLMNAMAPT
SCHEMBL17924880 0.87 MGLL (0.44) MGLLALDH1A1BLMLMNAMAPT
SCHEMBL44138 0.86 MGLL (0.46) MGLLALDH1A1BLMLMNAMAPT
SCHEMBL17924835 0.83 MGLL (0.44) MGLLALDH1A1BLMLMNAMAPT
SCHEMBL25704072 0.82 MGLL (0.48) MGLLALDH1A1BLMLMNAMAPT
SCHEMBL8097844 0.82 MGLL (0.48) MGLLALDH1A1BLMLMNAMAPT
SCHEMBL17924896 0.82 MGLL (0.45) MGLLALDH1A1BLMLMNAMAPT
SCHEMBL17924945 0.78 MGLL (0.45) MGLLALDH1A1BLMLMNAMAPT
SCHEMBL31071892 0.78 MGLL (0.35) MGLLALDH1A1BLMLMNAMAPT
SCHEMBL17924825 0.78 MGLL (0.45) MGLLALDH1A1BLMLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3515476-A1 FUSION COMPRISING A CELL PENETRATING PEPTIDE, A MULTI EPITOPE AND A TLR PEPTIDE AGONIST FOR TREATMENT OF CANCER Amal Therapeutics SA (CH) 2019-07-31 EP disclosed
WO-2018055060-A1 FUSION COMPRISING A CELL PENETRATING PEPTIDE, A MULTI EPITOPE AND A TLR PEPTIDE AGONIST FOR TREATMENT OF CANCER AMAL THERAPEUTICS SA (CH) 2018-03-29 WO disclosed
EP-3270957-A1 A NOVEL COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST FOR TREATMENT OF GLIOBLASTOMA Amal Therapeutics SA (CH) 2018-01-24 EP disclosed
EP-3270955-A1 A NOVEL COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST FOR TREATMENT OF COLORECTAL CANCER Amal Therapeutics SA (CH) 2018-01-24 EP disclosed
EP-3114138-A1 IMPROVED MUTEINS OF CLOTTING FACTOR VIII Pfizer Inc. (US) 2017-01-11 EP disclosed
WO-2016146143-A1 CELL PENETRATING PEPTIDES AND COMPLEXES COMPRISING THE SAME AMAL THERAPEUTICS SA (CH) 2016-09-22 WO disclosed
WO-2016146262-A1 A NOVEL COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST FOR TREATMENT OF COLORECTAL CANCER AMAL THERAPEUTICS SA (CH) 2016-09-22 WO disclosed
WO-2016146259-A1 A NOVEL COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST FOR TREATMENT OF GLIOBLASTOMA AMAL THERAPEUTICS SA (CH) 2016-09-22 WO disclosed
WO-2015132724-A1 IMPROVED MUTEINS OF CLOTTING FACTOR VIII PFIZER INC. (US) 2015-09-11 WO disclosed
EP-2097117-A1 IMPLANT OF CROSS-LINKED SPIDER SILK THREADS Medizinische Hochschule Hannover (DE) 2009-09-09 EP disclosed
WO-2008071226-A1 IMPLANT OF CROSS-LINKED SPIDER SILK THREADS MEDIZINISCHE HOCHSCHULE HANNOVER (DE) 2008-06-19 WO disclosed